Dhanvantri Jeev.

{
  "main_header": {
    "sid": 185785,
    "name": "Dhanvantri Jeev.",
    "stock_name": "Dhanvantri Jeev.",
    "full_name": "Dhanvantri Jeevan Rekha Ltd",
    "name_url": "stocks-analysis/dhanvantri-jeev",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "25.14",
    "chg": 1.19,
    "chgp": "4.97%",
    "dir": 1,
    "prev_price": "23.95",
    "mcapval": "10.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531043,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE239F01015",
    "curr_date": "Mar 30",
    "curr_time": "",
    "bse_nse_vol": "105 ",
    "exc_status": "Active",
    "traded_date": "Mar 30, 2026",
    "traded_date_str": "2026 03 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dhanvantri-jeev-185785-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Dhanvantri Jeevan Rekha Ltd Upgraded to Sell on Technical Improvements Despite Fundamental Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dhanvantri-jeevan-rekha-ltd-upgraded-to-sell-on-technical-improvements-despite-fundamental-challenges-3902386",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DhanvantriJeeva_mojoScore_3902386.png",
        "date": "2026-03-20 08:06:23",
        "description": "Dhanvantri Jeevan Rekha Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 19 Mar 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but positive shift in the company’s outlook despite lingering fundamental challenges."
      },
      {
        "title": "Dhanvantri Jeevan Rekha Ltd Downgraded to Strong Sell Amid Technical and Fundamental Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dhanvantri-jeevan-rekha-ltd-downgraded-to-strong-sell-amid-technical-and-fundamental-concerns-3884508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DhanvantriJeeva_mojoScore_3884508.png",
        "date": "2026-03-11 08:09:57",
        "description": "Dhanvantri Jeevan Rekha Ltd, a player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 10 March 2026. This revision reflects a combination of deteriorating technical indicators, weak long-term fundamentals, and valuation concerns despite some recent positive quarterly financial results."
      },
      {
        "title": "Dhanvantri Jeevan Rekha Ltd Downgraded to Strong Sell Amid Technical and Fundamental Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dhanvantri-jeevan-rekha-ltd-downgraded-to-strong-sell-amid-technical-and-fundamental-concerns-3875279",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DhanvantriJeeva_mojoScore_3875279.png",
        "date": "2026-03-06 08:04:21",
        "description": "Dhanvantri Jeevan Rekha Ltd, a player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 5 March 2026. This shift reflects a complex interplay of deteriorating technical indicators, weak long-term financial fundamentals, and valuation concerns despite some recent positive quarterly results. The company’s Mojo Score now stands at 29.0, signalling heightened caution for investors amid volatile market conditions and subdued operational performance."
      },
      {
        "title": "Dhanvantri Jeevan Rekha Ltd Downgraded to Strong Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dhanvantri-jeevan-rekha-ltd-downgraded-to-strong-sell-amid-mixed-financial-and-technical-signals-3846422",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DhanvantriJeeva_mojoScore_3846422.png",
        "date": "2026-02-19 08:11:24",
        "description": "Dhanvantri Jeevan Rekha Ltd, a player in the healthcare services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 Feb 2026. Despite some positive quarterly financial results, the company’s overall quality, valuation, financial trend, and technical indicators present a complex picture that has led to a cautious stance among investors."
      },
      {
        "title": "Are Dhanvantri Jeevan Rekha Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-dhanvantri-jeevan-rekha-ltd-latest-results-good-or-bad-3838180",
        "imagepath": "",
        "date": "2026-02-13 19:54:35",
        "description": "Dhanvantri Jeevan Rekha Ltd's latest financial results for Q3 FY26 indicate a notable operational recovery, with net sales reaching ₹7.27 crores, reflecting a year-on-year growth of 27.54%. This marks a significant improvement compared to the previous year, where the growth was only 10.68%. The company's net profit also showed a positive trend, amounting to ₹0.17 crores, which is a 13.33% increase from the same quarter last year, contrasting with a substantial loss in the prior year.\n\nThe operating margin for the quarter stood at 3.99%, the highest in eight quarters, suggesting an improvement in operational efficiency. However, the company continues to face challenges in capital efficiency, as evidenced by an average return on equity of 2.25% and a negative return on capital employed of -4.36%. These metrics highlight ongoing structural issues that the company must address to enhance shareholder value.\n\nDes..."
      },
      {
        "title": "Dhanvantri Jeevan Rekha Q3 FY26: Operational Recovery Masks Underlying Fragility",
        "link": "https://www.marketsmojo.com/news/result-analysis/dhanvantri-jeevan-rekha-q3-fy26-operational-recovery-masks-underlying-fragility-3836127",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DhanvantriJeeva_quaterlyResult_3836127.png",
        "date": "2026-02-12 20:16:47",
        "description": "Dhanvantri Jeevan Rekha Ltd., a micro-cap healthcare services provider based in Meerut, reported a sharp operational turnaround in Q3 FY26, posting net profit of ₹0.17 crores—a dramatic recovery from the ₹0.14 crore loss recorded in Q2 FY26. However, with a market capitalisation of just ₹10.00 crores and elevated valuation metrics, the company's financial fragility remains a significant concern for investors despite the sequential improvement."
      },
      {
        "title": "Are Dhanvantri Jeevan Rekha Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-dhanvantri-jeevan-rekha-ltd-latest-results-good-or-bad-3835703",
        "imagepath": "",
        "date": "2026-02-12 19:45:41",
        "description": "Dhanvantri Jeevan Rekha Ltd's latest financial results for Q2 FY26 present a complex picture characterized by contrasting operational trends. The company reported a net profit of -₹0.14 crores, a notable shift from a profit of ₹0.06 crores in the previous quarter, indicating a significant decline in profitability. This marks a concerning reversal from the modest profits observed in the prior two quarters.\n\nOn the revenue front, Dhanvantri Jeevan Rekha achieved a net sales figure of ₹5.84 crores, reflecting a year-on-year growth of 7.75% and a sequential increase of 5.99%. This revenue performance represents the highest quarterly sales in seven quarters, indicating a positive trend in top-line growth. However, this growth did not translate into improved profitability, as the operating margin fell to -1.20%, the lowest level in seven quarters, highlighting challenges in managing operational costs effectively...."
      },
      {
        "title": "When is the next results date for Dhanvantri Jeevan Rekha Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-dhanvantri-jeevan-rekha-ltd-3825170",
        "imagepath": "",
        "date": "2026-02-06 23:18:05",
        "description": "The next results date for Dhanvantri Jeevan Rekha Ltd is scheduled for 12 February 2026...."
      },
      {
        "title": "Dhanvantri Jeevan Rekha Ltd Downgraded to Sell Amid Mixed Technicals and Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dhanvantri-jeevan-rekha-ltd-downgraded-to-sell-amid-mixed-technicals-and-weak-fundamentals-3821826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DhanvantriJeeva_mojoScore_3821826.png",
        "date": "2026-02-05 08:12:42",
        "description": "Dhanvantri Jeevan Rekha Ltd, a player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 4 February 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent fundamental challenges. The upgrade is driven primarily by improvements in technical indicators, while valuation and financial trends remain subdued, underscoring a cautious stance for investors."
      }
    ],
    "total": 484,
    "sid": "185785",
    "stock_news_url": "https://www.marketsmojo.com/news/dhanvantri-jeevan-rekha-185785"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2026",
      "details": "Closure of trading window March 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Feb-2026",
      "details": "PFA the newsapaper clipping of the result quater ending dec 2025",
      "source": "BSE"
    },
    {
      "caption": "Result Forquater Dec 2025",
      "datetime": "12-Feb-2026",
      "details": "Please find the result for the dec quarter 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dhanvantri Jeevan Rekha Ltd has declared <strong>4%</strong> dividend, ex-date: 15 Sep 11",
          "dt": "2011-09-15",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Dhanvantri Jeevan Rekha Ltd Upgraded to Sell on Technical Improvements Despite Fundamental Challenges

2026-03-20 08:06:23

Dhanvantri Jeevan Rekha Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 19 Mar 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but positive shift in the company’s outlook despite lingering fundamental challenges.

Read full news article

Dhanvantri Jeevan Rekha Ltd Downgraded to Strong Sell Amid Technical and Fundamental Concerns

2026-03-11 08:09:57

Dhanvantri Jeevan Rekha Ltd, a player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 10 March 2026. This revision reflects a combination of deteriorating technical indicators, weak long-term fundamentals, and valuation concerns despite some recent positive quarterly financial results.

Read full news article

Dhanvantri Jeevan Rekha Ltd Downgraded to Strong Sell Amid Technical and Fundamental Concerns

2026-03-06 08:04:21

Dhanvantri Jeevan Rekha Ltd, a player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 5 March 2026. This shift reflects a complex interplay of deteriorating technical indicators, weak long-term financial fundamentals, and valuation concerns despite some recent positive quarterly results. The company’s Mojo Score now stands at 29.0, signalling heightened caution for investors amid volatile market conditions and subdued operational performance.

Read full news article

Dhanvantri Jeevan Rekha Ltd Downgraded to Strong Sell Amid Mixed Financial and Technical Signals

2026-02-19 08:11:24

Dhanvantri Jeevan Rekha Ltd, a player in the healthcare services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 Feb 2026. Despite some positive quarterly financial results, the company’s overall quality, valuation, financial trend, and technical indicators present a complex picture that has led to a cautious stance among investors.

Read full news article

Are Dhanvantri Jeevan Rekha Ltd latest results good or bad?

2026-02-13 19:54:35

Dhanvantri Jeevan Rekha Ltd's latest financial results for Q3 FY26 indicate a notable operational recovery, with net sales reaching ₹7.27 crores, reflecting a year-on-year growth of 27.54%. This marks a significant improvement compared to the previous year, where the growth was only 10.68%. The company's net profit also showed a positive trend, amounting to ₹0.17 crores, which is a 13.33% increase from the same quarter last year, contrasting with a substantial loss in the prior year. The operating margin for the quarter stood at 3.99%, the highest in eight quarters, suggesting an improvement in operational efficiency. However, the company continues to face challenges in capital efficiency, as evidenced by an average return on equity of 2.25% and a negative return on capital employed of -4.36%. These metrics highlight ongoing structural issues that the company must address to enhance shareholder value. Des...

Read full news article

Dhanvantri Jeevan Rekha Q3 FY26: Operational Recovery Masks Underlying Fragility

2026-02-12 20:16:47

Dhanvantri Jeevan Rekha Ltd., a micro-cap healthcare services provider based in Meerut, reported a sharp operational turnaround in Q3 FY26, posting net profit of ₹0.17 crores—a dramatic recovery from the ₹0.14 crore loss recorded in Q2 FY26. However, with a market capitalisation of just ₹10.00 crores and elevated valuation metrics, the company's financial fragility remains a significant concern for investors despite the sequential improvement.

Read full news article

Are Dhanvantri Jeevan Rekha Ltd latest results good or bad?

2026-02-12 19:45:41

Dhanvantri Jeevan Rekha Ltd's latest financial results for Q2 FY26 present a complex picture characterized by contrasting operational trends. The company reported a net profit of -₹0.14 crores, a notable shift from a profit of ₹0.06 crores in the previous quarter, indicating a significant decline in profitability. This marks a concerning reversal from the modest profits observed in the prior two quarters. On the revenue front, Dhanvantri Jeevan Rekha achieved a net sales figure of ₹5.84 crores, reflecting a year-on-year growth of 7.75% and a sequential increase of 5.99%. This revenue performance represents the highest quarterly sales in seven quarters, indicating a positive trend in top-line growth. However, this growth did not translate into improved profitability, as the operating margin fell to -1.20%, the lowest level in seven quarters, highlighting challenges in managing operational costs effectively....

Read full news article

When is the next results date for Dhanvantri Jeevan Rekha Ltd?

2026-02-06 23:18:05

The next results date for Dhanvantri Jeevan Rekha Ltd is scheduled for 12 February 2026....

Read full news article

Dhanvantri Jeevan Rekha Ltd Downgraded to Sell Amid Mixed Technicals and Weak Fundamentals

2026-02-05 08:12:42

Dhanvantri Jeevan Rekha Ltd, a player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 4 February 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent fundamental challenges. The upgrade is driven primarily by improvements in technical indicators, while valuation and financial trends remain subdued, underscoring a cautious stance for investors.

Read full news article

View All News